Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman M Chabanon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Research|March 15, 2022
A Novel Synthetic Lethal Approach to Target MYC-Driven CancersRoman M Chabanon, Sophie Postel-Vinay
Seminars in Cancer Biology|October 1, 2019
Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancersRoman M Chabanon, Daphné Morel, Sophie Postel-Vinay
Seminars in Cancer Biology|December 28, 2019
Understanding genetic determinants of resistance to immune checkpoint blockersSandrine Aspeslagh, Roman M Chabanon, Stéphane Champiat, et al.
Genome Medicine|November 4, 2025
Genome instability and crosstalk with the immune responseRoman M Chabanon, François-Xavier Danlos, Kaissa Ouali, et al.
Molecular & Cellular Oncology|May 28, 2019
Beyond DNA repair: the novel immunological potential of PARP inhibitorsRoman M Chabanon, Jean-Charles Soria, Christopher J Lord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Mutational Landscape and Sensitivity to Immune Checkpoint BlockersRoman M Chabanon, Marion Pedrero, Céline Lefebvre, et al.
Nature Reviews. Cancer|August 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunitiesRoman M Chabanon, Mathieu Rouanne, Christopher J Lord, et al.
The Journal of Clinical Investigation|December 28, 2018
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancerRoman M Chabanon, Gareth Muirhead, Dragomir B Krastev, et al.
The Journal of Clinical Investigation|February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockadeMehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.
Nature Communications|July 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancersRoman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Research|March 15, 2022
A Novel Synthetic Lethal Approach to Target MYC-Driven CancersRoman M Chabanon, Sophie Postel-Vinay
Seminars in Cancer Biology|October 1, 2019
Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancersRoman M Chabanon, Daphné Morel, Sophie Postel-Vinay
Seminars in Cancer Biology|December 28, 2019
Understanding genetic determinants of resistance to immune checkpoint blockersSandrine Aspeslagh, Roman M Chabanon, Stéphane Champiat, et al.
Genome Medicine|November 4, 2025
Genome instability and crosstalk with the immune responseRoman M Chabanon, François-Xavier Danlos, Kaissa Ouali, et al.
Molecular & Cellular Oncology|May 28, 2019
Beyond DNA repair: the novel immunological potential of PARP inhibitorsRoman M Chabanon, Jean-Charles Soria, Christopher J Lord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Mutational Landscape and Sensitivity to Immune Checkpoint BlockersRoman M Chabanon, Marion Pedrero, Céline Lefebvre, et al.
Nature Reviews. Cancer|August 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunitiesRoman M Chabanon, Mathieu Rouanne, Christopher J Lord, et al.
The Journal of Clinical Investigation|December 28, 2018
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancerRoman M Chabanon, Gareth Muirhead, Dragomir B Krastev, et al.
The Journal of Clinical Investigation|February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockadeMehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.
Nature Communications|July 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancersRoman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki, et al.
Pageof 2